The GIFT Nifty futures, which are an early indicator of the Nifty50 index stocks, were trading lower by 117 points at 23,940, indicating that the domestic benchmark indices are likely to make a negative start on Thursday. 

Earlier on Wednesday, 8 April, the domestic benchmark indices S&P BSE Sensex surged by 2,946 points or 3.95%, and settled at 77,568, while the Nifty50 traded 3.78% higher or 873 points, closing at 23,997.

Here are some stocks that are likely to remain in focus on 9 April.

Lupin: The company received approval from the United States Food and Drug Administration for Dapagliflozin and Metformin Hydrochloride extended-release tablets in multiple strengths, including 5 mg/500 mg, 5 mg/1,000 mg, 10 mg/500 mg, and 10 mg/1,000 mg.

KEC International: The company secured new orders worth Rs 2,518 crore across its civil, transportation & distribution, and cable & conductors segments.

RITES: The company secured engineering and project management consultancy (PMC) work for constructing a railway siding at Sankerjang under Phase I of the Utkal-D coal mines project for National Aluminium Company. The contract value increased from Rs 79.73 crore to Rs 118.89 crore.

NTPC: The company signed a non-binding Memorandum of Understanding (MoU) with Électricité de France to explore collaboration in developing new nuclear power projects in India.

Jet Airways: The liquidator, Satish Kumar Gupta, put up two Delhi-based Boeing 777 aircraft of Jet Airways (India) for sale through an e-auction. Ace Aviation XIV emerged as the winning bidder for both aircraft, placing a total bid of Rs 568.17 crore against a reserve price of Rs 356.75 crore.

Network People Services Technologies: The company won an order from a public sector bank to deploy its AI-powered Risk Intelligence and Decision Platform (RIDP) for merchant underwriting and monitoring.

Discover the next big investment! Tradz by EquityPandits’ IPO screener helps you identify promising initial public offerings. Download Tradz by EquityPandit and get ahead of the curve! Sign Up Now & Find Your Next IPO Gem!